MedTrace Logo

Method of Early Diagnosis of Laryngopharyngeal Reflux

NCT04771221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 385

Last updated 2023-01-10

No results posted yet for this study

Summary

The investigator will issue a Patient Information Consent for the participant in the study. 1.Patients will be asked to complete the Reflux Symptom Index questionnaire.

Clinical survey, medical history. 2. Objective methods for assessing the patient's condition:

\- examination of ENT organs. 3. Laboratory and instrumental research methods: Endoscopic laryngoscopy and video laryngoscopy, pH-metry, acoustic voice analysis.

4.Sociological method. 5. Subjective methods for assessing the condition of the larynx. 6. Аnalysis of the received data

Conditions

  • Laryngopharyngeal Reflux
  • Laryngopharyngitis Chronic
  • Gastro Esophageal Reflux
  • Laryngitis

Interventions

DIAGNOSTIC_TEST

pH metry

The collection of mucus from the laryngopharynx to determine the acid-base values through pH-metry.

DIAGNOSTIC_TEST

Filling out the questionnaire

Completion of the questionnaire index of reflux symptoms. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. Evaluation results range from 0 to 5, where 0 is an indicator of no problem, and 5 is an indicator of a serious problem

DEVICE

Endoscopic laryngoscopy

Video laryngoscopy and assessment of the presence / severity of the symptoms. Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem

DEVICE

Acoustic voice analysis

acoustic analysis of the voice was performed in singers with voice disorders before and after treatment using program of the Lingwaves

Sponsors & Collaborators

  • Kazakh Medical University of Continuing Education

    lead OTHER

Principal Investigators

  • Nukusbekova · Doctor

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-10
Primary Completion
2022-02-15
Completion
2022-02-15

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04771221 on ClinicalTrials.gov